Page 1578 - Small Animal Internal Medicine, 6th Edition

1550 Index

Betamethasone, 1222t Bitch (Continued) Blood glucose (Continued) Brain natriuretic peptide, 13
Bethanechol, 440–441, 456, 515t–517t, ovariohysterectomized, reproductive serial curves of dilated cardiomyopathy and, 144
tract disorders in
733t–734t, 1185t–1186t chronic vestibulovaginitis, 980–982, in cats, 837 Brain tumors, 1081
synthesis of, 58
VetBooks.ir Bicytopenia, 1382b ovarian remnant syndrome, Blood groups, 1356–1357 Brainstem
Bicarbonate, 432
in dogs, 819–822, 820f–821f,
980f–982f
therapy, 842b, 844–845
823f–824f
anatomy of, 1037
lesions of, 1038b
Bifidobacterium, 443
982–983, 983f
Big kidney, little kidney syndrome, 715, ovulation timing in, 940–945 Blood loss anemia, 1345–1346, 1345t Brainstem auditory evoked response,
Blood pressure
715f pregnancy in. see also Pregnancy abnormal, 131 1072
Bigeminy, 6 brucellosis, 963–965 classification of, 211 Breathing
Bilateral motor paralysis, 1059f pregnancy loss, 962 control agents, chronic kidney disease, open-mouth, 4, 4f
Bile duct, obstruction of. see semen peritonitis, 961–962 702 rate of, 4
Extrahepatic bile duct obstruction pseudopregnancy in, 957 Doppler ultrasonic measurement of, Breathing pattern
Bile peritonitis, 603 silent heat cycle in, 953 215 in laryngeal diseases, 271
Biliary cysts, feline, 575 split heat cycle in, 953–954 elevated levels of. see Hypertension in respiratory distress, 284
Biliary tract vagina of indirect measurement of, 214–215 Breeding husbandry
diseases and disorders of, 599–603 hyperplasia of, 957–958, 958f measurement of, 214–217 artificial insemination
in cats. see Feline biliary tract illustration of, 941f oscillometric measurement method intrauterine, 947–948, 947f–948f
disease vestibule of, 941f for, 215 transcervical, 947–948, 948f
cholangitis, 599–600 Biventricular failure, heart, 1 pathophysiology of, 212 vaginal, 947
cholecystitis, 599–600 Bladder regulation of, 212 semen analysis, 946–947, 946f
extrahepatic bile duct obstruction, overactive, 736–737 Blood pressure cuffs, 214 semen collection, 945–946, 945b
601–603 transitional cell carcinoma of, 736 Blood transfusion Breeding management
gallbladder mucocele, 600–601, 600f metastasis of, 1290t description of, 1356 of bitch, 944–945
obstruction of, acute pancreatitis and, Bladder tumor antigen test, 662 immune-mediated hemolytic anemia of queen, 944–945
633 “Bland” diets, 434, 434b treated with, 1237 Brethine. see Terbutaline; Terbutaline
Bilious vomiting syndrome, 470 Blast crisis, 1311 Blood typing, 1357 sulfate
Bilirubin, in urine, 665 Blast transformation, 1311 Blood urea nitrogen, 658 Bromocriptine, 955
Bilirubinuria, 525–527, 526f–527f Blastomyces dermatitidis, 1502, 1503f, Blood vessels, intrathoracic, 16–18 Bronchi
Binaural eartubes, of stethoscope, 7, 7f 1503t, 1505 Body condition scoring, 901, 902f–903f, bronchoscopy of, 314t
Biomarkers, cardiac, 13–14 Blastomycosis, 1502–1505 907 disorders of, 283b
Biopsy antifungal drugs for, 1504t Body surface area, 1271, 1271t–1272t Bronchial asthma, 330b
chronic pancreatitis, 636 clinical features of, 1502 Body temperature, of neonates, 1010b Bronchial pattern, 290, 290f–291f, 290b,
endoscopic, 429–430 cytologic appearance, 1503f, 1503t Body weight conversions to body surface 293f
fine-needle aspiration, 429 diagnosis of, 1502–1504, 1503f area Bronchiectasis, 290, 325, 325f
full-thickness, 430 epidemiology of, 1502 in cats, 1272t Bronchitis
liver, 553–559, 554f etiology of, 1502 in dogs, 1271, 1271t allergic, 329t, 337
indications for, 554 lymphadenopathy and, 1502 Body weight measurements, 901 canine chronic. see Canine chronic
techniques for, 554–555, 555f–558f ocular manifestation of, 1502 Boehringer Ingelheim. see Cabergoline bronchitis
muscle, 1073 prevention of, 1505 Bone marrow aplasia-hypoplasia, feline. see Feline bronchitis
nasal relapse of, 1505 1353–1354, 1384–1385 mycoplasmal, 329t
complications of, 255 treatment of, 1504–1505, 1504t Bone marrow disorders, 1353–1354, Bronchoalveolar lavage
hemorrhage caused by, 255 zoonotic aspects of, 1505 1355b advantages and disadvantages of, 299t
indications for, 253–255 Bleeding Bone marrow suppression, 735 canine chronic bronchitis evaluations,
nasal flush, 254 clinical manifestations of, 1388–1389, Bone metastases, 1290 326
nasal swabs, 254 1388b, 1391f Border Collie collapse (BCC), 1107, diagnostic yield, 310, 310f
pinch biopsy, 254–255, 254f clinicopathologic evaluation of, 1183–1184 heartworm disease evaluations, 206
techniques for, 253–255 1389–1393, 1390f Bordetella spp. interpretation of results, 309–310
turbinectomy, 255 delayed postoperative, 1389 B. bronchiseptica, 259, 321, 322f, 1453, pulmonary neoplasia findings, 352f
nerve, 1073 management of, 1393–1394 1455, 1533t–1535t, 1542 recovery from, 308–309
pancreatic, 558–559 spontaneous, 1388–1389, 1391f prevention of, 324 specimen handling, 309
pinch, 254–255, 254f β-Blockers respiratory epithelium affected by, 321 Bronchodilators
renal, 672–673, 690 antiarrhythmic effects of, 93–95 Borrelia burgdorferi, 153, 1128, 1194, aspiration pneumonia treated with,
splenic, 1416–1417 characteristics of, 94t 1440t, 1469, 1533t–1535t. see also 347–348
synovial membrane, 1193 electrocardiographic changes Lyme disease bacterial pneumonia treated with, 343
testicular, 1003–1004 associated with, 49b Botulism, 1167t, 1169 feline bronchitis treated with, 332
Biosol. see Neomycin in heart failure, 73 Boxers idiopathic pulmonary fibrosis treated
Bipyridine phosphodiesterase inhibitors, hypertension treated with, 217t arrhythmogenic right ventricular with, 351
63–65 nonselective, 93 cardiomyopathy in, 148, 1363 pulmonary parenchymal disorders
Bisacodyl, 445t, 515t–517t pulmonic stenosis treated with, cardiac tamponade in, 178f treated with, 381–382
Bismuth subsalicylate, 441, 515t–517t 108–109 paroxysmal ventricular tachycardia in, Bronchoscopy, 309t, 312
Bisphosphonates, 927 subaortic stenosis treated with, 149f airway collapse evaluations of, 335
Bitch 107 Brachial plexus avulsion, 1158t, 1159f aspiration pneumonia evaluations, 347
artificial insemination of, 947, 947f Blood cultures, 133–134 Brachycephalic airway syndrome, canine chronic bronchitis evaluations,
breeding management of, 944–945 Blood gas analysis, 313–318 279–280, 279f, 380–381 326
breeding soundness consultations in, acid-base status, 318 Bradyarrhythmias, 86–88 indications for, 312
935–936 alveolar-arterial gradient, 317–318, algorithm for, 86f Oslerus osleri on, 338f
cystic endometrial hyperplasia/ 317t, 318b atrial standstill, 87 technique for, 312, 313f
pyometra complex, 985–988, dorsal pedal artery, 314, 315f atrioventricular conduction block, Brucella canis, 963–964, 1441t, 1446,
986f–987f, 987t femoral artery, 314, 315f 87–88 1533t–1535t, 1543
estrous cycle in indications for, 313 sick sinus syndrome, 86–87, 87f Brucellosis, 963–965, 1000
abnormalities of, 954–958 oxygen content, delivery, and sinus bradycardia. see Sinus Bubonic plague, 1541
description of, 937–940, 938t utilization, 318 bradycardia Buccal mucosa bleeding time, 1389,
variations of, 953–954 partial pressure of carbon dioxide treatment of, 86f 1391b
exaggerated pseudocyesis in, 957 (PaCO 2), 315–317, 316b Bradycardia, 37 Budesonide, 441, 515t–517t
infertility/subfertility in, 984, 984b partial pressure of oxygen (PaO 2), Bradycardia-tachycardia syndrome, 86, Bulbourethral reflex, 1049t, 1050
microbiology and, 984–985, 985b 315–317, 316b 87f Bulk laxatives, 445
labor in, 968 results of, 315–318, 315t Bradyzoites, 1520 Bulking agents, 445t
later than typical puberty in, 953 techniques of, 313–314, 315f Brain Bundle branch block
metabolic disorders in, 966–967 ventilation/perfusion ratio, 316 anatomy of, 1037–1039, 1038f left, 44, 46b
gestational diabetes, 967, 967f Blood glucose cerebellum, 1038–1039 patterns, 45–46
hyperemesis gravidarum, 966–967 for diabetes mellitus monitoring in degenerative disorders of, 1080 right, 44, 45f, 46b
pregnancy edema, 967, 968f dogs, 818 forebrain, 1037 Buprenorphine, 19–20, 629t–630t, 1268t
pregnancy thrombosis, 967, 967f measurement of infective endocarditis effects on, 134b analgesic uses of, 227b
pregnancy toxemia, 967 in cats, 838f medulla, 1037–1038 dosage of, 1134t
vasculitides, 967 methods for, 821 pons, 1037–1038 stress relief using, 380t